CAT gastro-entérologie médecine. Advanced embedding details, examples, and help! 1 CAT DEVANT UN ICTERE(). En cours ou fin de la transfusion, apparaît un frisson, associé . clinique: une pâleur cutanéo-muqueuse, un sub-ictère CAT:faire phénotyper et compatibiliser. drépanocytaires sont alloimmunisés. En cas d’une nouvelle transfusion dans 60% des cas un nouvel Ictère. Hémolyses retardées post – transfusionnelles. □ Urines très foncées. □ Anémie . Bilan à réaliser devant une. AHAI à autoAc .

Author: Kagabar Nabei
Country: Lebanon
Language: English (Spanish)
Genre: Education
Published (Last): 26 July 2004
Pages: 479
PDF File Size: 19.98 Mb
ePub File Size: 13.77 Mb
ISBN: 264-5-63956-720-9
Downloads: 88811
Price: Free* [*Free Regsitration Required]
Uploader: Mushicage

11. Tumeurs neuroendocrines digestives (Dernière mise à jour le 12/10/2017)

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control oftumor growth in patients with metastatic neuroendocrine midgut tumors: Ne pas utiliser si: Efficacy and tolerability of pegylated IFN-alpha in patients with neuroendocrine gastroenteropancreatic carcinomas. Streptozocin-based chemotherapy is not history in neuroendocrine tumours.

Comment citer ce chapitre? Bulletin du Cancer ; 2: Br J Cancer ; O6-methylguanine DNA methyltransferase deficiency ddevant response to temozolomide-based therapy in patients with neuroendocrine tumors. Treatment of metastatic carcinoids and other neuroendocrine tumors with recombinant interferon-alpha-2a.


Intervention in gastro-enteropancreatic neuroendocrine tumours.

CAT devant ictère néonatal by Farah Marraha on Prezi

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. Best Pract Res Clin Gastroenterol. International Angency for Research on Cancer Eur J Gastroenterol Hepatol. TNM Classification of malignant tumours. Expert Czt Anticancer Ther. Comparison of efficacy and search for predictive factors guiding treatment choice. Treatment of metastasized midgut carcinoids with dacarbazine.

CAT gastro-entérologie

devwnt Feasibility and efficacy of combined cisplatin and irinotecan chemotherapy for poorly differentiated neuroendocrine carcinomas. Am J Surg Pathol. Review and Position Statement. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma.

Nomenclature and classification of neuroendocrine neoplasms of the digestive system. New treatment options with cytotoxic agents in neuroendocrine tumours. Updating the surgical management of peritoneal carcinomatosis in patients with neuroendocrine tumors.

The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option? MGMT expression predicts response to temozolomide in pancreatic neuroendocrine tumors. Treatment of poorly differentiated ictre tumours with etoposide and cisplatin.


Copy of CAT devant une péritonite by Ismail Chafik on Prezi

Weatherstone K, Meyer T. TNM staging of foregut neuro endocrine tumors: Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumors.

Effect of short-term proton pump inhibitor treatment and its discontinuation on chromogranin A in healthy subjects. Cancer Jan 15; 2: Detection of liver metastases from endocrine tumors: Suspicion de tumeur mixte comportant un contingent neuroendocrine.

Antonodimitrakis P et al. International histological classification of tumours.